{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-002850","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2026-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.573006+00:00","generated_at":"2026-05-16T09:36:42.397723+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Indaptus cuts co-CEO and CSO salaries to $60K/year; director rescinds resignation","bullets":["Co-CEO Jeffrey A. Meckler and CSO Michael J. Newman salaries reduced to $60,000 per annum effective Jan 15, 2026.","Director Anthony Maddaluna rescinded his prior resignation and will remain on the Board, including Compensation and Nominating committees.","Salary adjustments are for the remainder of the 2026 calendar year and follow prior employment modifications from Dec 2025.","The reductions are part of a cost-saving measure tied to a securities purchase agreement with investor David E. Lazar."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-002850","json":"https://secwatch.observer/filing/0001493152-26-002850.json","markdown":"https://secwatch.observer/filing/0001493152-26-002850.md","text":"https://secwatch.observer/filing/0001493152-26-002850.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226002850/0001493152-26-002850-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226002850/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:36:42.397723+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}